Every quarter, many money managers have to disclose what they've bought and sold. Their latest moves can shine a bright light on smart stock picks.
Today, let's look at Barrow, Hanley, Mewhinney & Strauss, one of the biggest value-focused institutional investment companies around, with more than $46 billion in assets as of Dec. 31, 2011. According to the folks at GuruFocus.com, over the 15 years ended in 2011, Barrow, Hanley racked up a cumulative gain of 178%, compared with just 120% for the S&P 500.
The company aims to invest via portfolios that maintain below-average price-to-earnings (P/E) ratios, below-average price-to-book ratios, and above-market-average dividend yields. It also tends to focus on large-cap companies.
The company's top holdings as of the end of 2011 were Philip Morris International, ConocoPhillips, and Occidental Petroleum.
So what does Barrow, Hanley's latest quarterly 13F filing tell us? Here are a few interesting details:
New holdings include Embraer
Among holdings in which Barrow, Hanley increased its stake were Walgreen
Barrow, Hanley reduced its stake in a lot of companies, including food distribution giant Sysco
Finally, Barrow, Hanley unloaded several companies, such as aluminum titan Alcoa
If you're in the market for other health-related stocks than Walgreen or Teva, check out our special free report, "Discover the Next Rule-Breaking Multibagger." It will introduce you to a fast-growing company with great potential in the robotic surgery field -- and it might not be the company you're thinking of.
We should never blindly copy any investor's moves, no matter how talented the investor. But it can be useful to keep an eye on what smart folks are doing, and 13-F forms can be great places to find intriguing candidates for our portfolios.Longtime Fool contributor Selena Maranjian, whom you can follow on Twitter, owns shares of Teva Pharmaceutical Industries, but she holds no other position in any company mentioned. Click here to see her holdings and a short bio. Motley Fool newsletter services have recommended buying shares of Sysco, Teva Pharmaceutical, Philip Morris International, and Embraer. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.
More from The Motley Fool
What Happened in the Stock Market Today
On a day the indexes pulled back from recent record highs, Wyndham announced it is buying La Quinta, and Alcoa reported disappointing profits.
Alcoa (AA) Q4 2017 Earnings Conference Call Transcript
AA earnings call for the period ending December 31, 2017.
Embraer, S.A. Had a Solid End to 2017
Embraer nailed down a slew of orders for its E175 regional jet in the last few months of 2017, bolstering its production outlook for the next two years.